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Pancreatic adenocarcinoma (PDAC) is one of the most lethal human cancers with a 5-
year survival of less than 5% due mostly to the lack of effective therapy and difficulty of 
detection at an early stage of development.   Recent studies have shown a high prevalence of 
S100 proteins in PDAC, in particular the calcium-binding protein S100P. It has been proposed 
that the metastasis-promoting calcium-binding protein S100P which possesses both intracellular 
and extracellular functions activates key cell signaling pathways, including MAP kinase and 
nuclear factor NFκB pathways through its extracellular interaction with the receptor for 
advanced glycation end products (RAGE). The interaction between RAGE-S100P stimulates 
pancreatic tumor proliferation, survival, invasion and metastasis progression in vitro and tumor 
metastasis in vivo. Using computational chemistry methods, our laboratory have identified 87 
novel compounds that prevent S100P binding to RAGE. Here in this talk we will outline the key 
challenges and methodology used to validate an ELISA to measure S100P and RAGE 
interaction. Our initial results highlight 22 new lead compounds that inhibit S100P-RAGE 
interaction, some of which have shown an ability to decrease pancreatic cell line growth. This 
work is supported by the Association for International cancer research and the University of 
Hertfordshire. 
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